Quote | First Wave BioPharma Inc. (NASDAQ:FWBI)
Last: | $2.96 |
---|---|
Change Percent: | -3.53% |
Open: | $2.93 |
Close: | $2.96 |
High: | $3.05 |
Low: | $2.83 |
Volume: | 56,362 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
News | First Wave BioPharma Inc. (NASDAQ:FWBI)
2024-05-16 07:44:01 ET More on First Wave BioPharma First Wave Biopharma to raise about $4M of proceeds in direct offering Seeking Alpha’s Quant Rating on First Wave BioPharma Read the full article on Seeking Alpha For further details see: First Wa...
Rebranding introduced as Company advances toward Phase 3 clinical trial with lead asset – latiglutenase for the treatment of celiac disease New Nasdaq ticker symbol is “ENTO” effective May 17, 2024 BOCA RATON, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Entero Ther...
Message Board Posts | First Wave BioPharma Inc. (NASDAQ:FWBI)
Subject | By | Source | When |
---|---|---|---|
Closed out today | starkd748 | investorshub | 03/09/2023 8:00:58 PM |
Look now | starkd748 | investorshub | 03/09/2023 1:02:06 PM |
Yeeeehaw | starkd748 | investorshub | 03/09/2023 12:48:14 PM |
Yup I thought it will double bottom at | starkd748 | investorshub | 02/22/2023 1:32:40 AM |
$4.26 | stock1ace1 | investorshub | 02/21/2023 8:02:54 PM |
News, Short Squeeze, Breakout and More Instantly...
First Wave BioPharma Inc. Company Name:
FWBI Stock Symbol:
NASDAQ Market:
Rebranding introduced as Company advances toward Phase 3 clinical trial with lead asset – latiglutenase for the treatment of celiac disease New Nasdaq ticker symbol is “ENTO” effective May 17, 2024 BOCA RATON, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Entero Ther...
BOCA RATON, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...